Your browser doesn't support javascript.
loading
ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer.
Hunt, Kelly K; Suman, Vera J; Wingate, Hannah F; Leitch, A Marilyn; Unzeitig, Gary; Boughey, Judy C; Meric-Bernstam, Funda; Ellis, Matthew J; Olson, John A.
Affiliation
  • Hunt KK; Breast Surgical Oncology, UT MD Anderson Cancer Center, 1400 Pressler St. Unit 1434, Houston, TX, 77030, USA. khunt@mdanderson.org.
  • Suman VJ; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA.
  • Wingate HF; Breast Surgical Oncology, UT MD Anderson Cancer Center, 1400 Pressler St. Unit 1434, Houston, TX, 77030, USA.
  • Leitch AM; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Unzeitig G; Doctor's Hospital of Laredo, Laredo, TX, USA.
  • Boughey JC; Mayo Clinic, Rochester, MN, USA.
  • Meric-Bernstam F; Breast Surgical Oncology, UT MD Anderson Cancer Center, 1400 Pressler St. Unit 1434, Houston, TX, 77030, USA.
  • Ellis MJ; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
  • Olson JA; Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA.
Ann Surg Oncol ; 30(4): 2119-2120, 2023 Apr.
Article in En | MEDLINE | ID: mdl-36745260

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: United States